会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • IN VITRO TEST FOR STUDYING COMPOUND PREDICTING PHARMACOLOGIC AND/OR PHARMACOKINETIC AND/OR PHARMACODYNAMIC PARAMETERS OF A COMPOUND
    • 用于研究化合物的化合物预防药物和/或药物动力学和/或药物动力学参数的体外试验
    • WO2004037160A2
    • 2004-05-06
    • PCT/IL2003/000876
    • 2003-10-23
    • YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEMTOUITOU, ElkaGODIN, Biana
    • TOUITOU, ElkaGODIN, Biana
    • A61K
    • C12Q1/025C12Q1/18
    • The invention provides a method and an assay for predicting the pharmacologic and/or pharmacokinetic and/or pharmacodynamic activity and/or effective concentration of a test material using cell and/or protozoa and/or micro-organism by assessing the effect of the test material on the and/or protozoa and/or micro-organism. Further, the invention provides an apparatus or a system, which comprises a donor and a receiver compartments, separated by membrane, wherein cell and/or protozoa and/or micro-organism are present in the receiver compartments, for predicting the pharmacologic of pharmacokinetic effects such as effective concentration of a test material, by assessing the effect of the test material, on the cell and/or protozoa and/or micro-organism. In addition, the invention provides use of an artificial human skin for measuring the diffusion or the penetration of a test material through the skin.
    • 本发明提供了一种用于通过评估测试材料的效果来预测使用细胞和/或原生动物和/或微生物的测试材料的药物和/或药物动力学和/或药效学活性和/或有效浓度的方法和测定法 在和/或原生动物和/或微生物上。 此外,本发明提供了一种装置或系统,其包括由膜分离的供体和接收器隔室,其中细胞和/或原生动物和/或微生物存在于接收器室中,用于预测药代动力学效应的药理学 例如通过评估测试材料对细胞和/或原生动物和/或微生物的影响来测试材料的有效浓度。 此外,本发明提供人造人皮肤用于测量测试材料通过皮肤的扩散或穿透的用途。